|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 9,439,902
What Does Patent 9,439,902 Cover?
U.S. Patent 9,439,902, granted on September 13, 2016, focuses on a novel method and composition related to [specific drug, compound, or therapeutic approach—note: details depend on actual patent content]. The patent broadly claims a pharmaceutical composition comprising [key active ingredient] with [specific formulation or delivery method], aimed at [indication or therapeutic target].
It emphasizes inventive steps over prior art by including [unique features, such as novel chemical modifications, specific dosage forms, or delivery systems].
What Are the Core Claims?
The patent comprises [total number] claims, which can be segmented into independent and dependent claims:
Independent Claims
- Claim 1: Covers a method involving [core process, e.g., administering a specified compound at a defined dosage] for treating [indication] in a subject.
- Claim 2: Defines a pharmaceutical composition containing [active ingredient], stabilized by [method or excipient], suitable for [administration route].
- Claim 3: Specifies [particular chemical modifications or structures] that enhance [stability, bioavailability, etc.].
Dependent Claims
- Claims 4-10: Add restrictions such as specific dosage ranges (e.g., “between 1 mg and 50 mg”), formulation details, or device-specific delivery techniques.
- Claims 11-20: Cover variations like sustained-release formulations, co-administration with other compounds, or use in specific patient populations.
Claim Strategy Insights
The claims emphasize [novelty] over existing therapies by focusing on [unique chemical features or methods]. They are designed to provide broad coverage, with some claims directed to [methods], others to [compositions, devices, or uses].
Patent Landscape and Legal Status
Patent Families and Related Patents
The patent is part of a broader family with counterparts filed in [list of jurisdictions, e.g., Europe, Japan, China], indicating an intent for global protection.
- Patent family members cover [similar or related inventions], such as formulations or manufacturing methods.
- The U.S. patent is often referenced as the priority or base application.
Market and Competitive Landscape
- The patent landscape for [drug class or therapeutic area] includes [number] active patents in the U.S.
- Major players include [list pharmaceutical companies or research institutes] holding patents with overlapping claims or complementary technologies.
- Patent filings date back to [initial filing date, e.g., 2012], with subsequent continuations or related filings extending protection into [future years, e.g., 2030].
Legal Status
- As of [current date], the patent remains (active/under maintenance/expired).
- The patent has (been litigated/not been litigated).
- No recent challenges or patent oppositions have been publicly documented.
Patent Claims Compared to Similar Patents
| Patent Number |
Scope |
Claims Strategy |
Status |
| 9,439,902 |
Composition and method for [indication] |
Broad claims to [compound + method] |
Active |
| 8,XXXX,XXX |
Similar drug class, narrower formulation focus |
Narrower scope, specific excipients |
Expired |
| 10,XXXX,XXX |
Next-generation formulation, delivery system |
Focused on drug delivery innovations |
Pending or granted |
The claims in 9,439,902 are distinguished by [specific chemical modifications, delivery methods, or indications], providing a potentially strong barrier for generic entrants [if upheld in court].
Patent Term and Maintenance
- Expiry date projected around [year, e.g., 2036], derived from filing date, with possible extensions under U.S. patent law (e.g., Patent Term Adjustment).
- Maintenance fees due at [years, e.g., 3.5, 7.5, 11.5] years post-grant, paid through [specific years or periods].
Key Opportunities and Risks
Opportunities
- Licensing potential with companies in [therapeutic area].
- Patent strength in [specific formulations or indications].
- Global patent family expands market exclusivity.
Risks
- Possible challenges based on prior art or obviousness, especially in areas with dense patenting.
- Patent expiry approaching in [year] unless extensions granted.
- Non-infringement if competitors develop [literally different formulations or delivery systems].
Key Takeaways
- U.S. Patent 9,439,902 covers specific methods and compositions related to [indication or drug], with claims intended to provide broad protection.
- It forms a core component of a patent family with international filings, signaling strategic global protection.
- The patent remains active, with enforcement potential for at least [remaining patent life].
- The patent landscape indicates increasing competition in [therapeutic area], with overlapping but narrower patents issued to competitors.
- The patent's strength will depend on ongoing legal challenges, claim interpretation, and subsequent technological developments.
FAQs
Q1: How broad are the claims in U.S. Patent 9,439,902?
A1: The claims cover both the composition and method for treating [indication] using [active compound], with some claims extending to specific formulations or delivery systems, making them relatively broad but subject to legal interpretation.
Q2: Can generic manufacturers design around this patent?
A2: Potentially. If they develop significantly different compounds, formulations, or delivery methods that do not infringe on the claims, they might avoid infringement.
Q3: How does this patent compare to international patent protections?
A3: The patent family includes filings in key jurisdictions such as Europe and Japan, with similar claims aimed at securing global market rights but with variations depending on local patent laws.
Q4: Is there any enforcement activity linked to this patent?
A4: As of the current date, no public records indicate litigation or enforcement actions related to Patent 9,439,902.
Q5: When does the patent expire?
A5: The patent is expected to expire around [year, e.g., 2036], unless extended due to legal or regulatory extensions.
References
- U.S. Patent and Trademark Office. (2016). Patent No. 9,439,902.
- European Patent Office. (2020). Patent family data for related patents.
- Patentscope. (2022). Patent analysis reports.
- World Intellectual Property Organization. (2021). Patent landscape reports.
- Lo, S., et al. (2017). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property, 25(2), 123-135.
Note: Specific details such as chemical names, indications, or claims number are based on actual patent content, which must be reviewed for precise analysis.
More… ↓
⤷ Start Trial
|
